Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Trends in Molecular Medicine|May 31, 2011
ER stress in retinal degeneration: a target for rational therapy?Ana Griciuc, Liviu Aron, Marius UeffingCurrent Opinion in Neurology|February 9, 2021
The role of innate immune genes in Alzheimer's diseaseAna Griciuc, Rudolph E TanziBiochimica Et Biophysica Acta|January 26, 2010
Clearance of Rhodopsin(P23H) aggregates requires the ERAD effector VCPAna Griciuc, Liviu Aron, Giovanni Piccoli, et al.Plos Genetics|September 25, 2010
Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in DrosophilaAna Griciuc, Liviu Aron, Michel J Roux, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 21, 2014
Proteomic survey reveals altered energetic patterns and metabolic failure prior to retinal degenerationAna Griciuc, Michel J Roux, Juliane Merl, et al.Scientific Reports|January 20, 2018
Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial PhagocytosisCan Zhang, Ana Griciuc, Eloise Hudry, et al.Neuron|April 30, 2013
Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid betaAna Griciuc, Alberto Serrano-Pozo, Antonio R Parrado, et al.Frontiers in Pharmacology|August 21, 2023
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's diseaseBen Boyarko, Sonia Podvin, Barry Greenberg, et al.Human Molecular Genetics|August 18, 2020
Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammationAna Griciuc, Anthony N Federico, Jeyashree Natasan, et al.Nature Reviews. Neuroscience|June 19, 2024
Gene therapy for CNS disorders: modalities, delivery and translational challengesJingjing Gao, Swetharajan Gunasekar, Ziting Judy Xia, et al.Pageof 2